转自：中国经济网 4月15日，英氏控股集团旗下高端婴童品牌舒比奇于长沙盛大举办 "中国婴幼儿专业敏感肌纸尿裤上市 发布会"，以 "医研共创 科学护敏" 为核心品牌主张，强势重新定义敏感肌护理品类。这场行业盛会汇 聚了医疗、科研、设计及母婴领域数百位权威专家，共同见证婴幼儿纸尿裤行业迈向专业化、科学化的 崭新里程碑。 中国婴幼儿专业敏感肌 纸尿裤革新上市现场仪式 当下，消费者对"红屁屁"防护的需求日益高涨。艾瑞咨询数据显示，宝妈在选购纸尿裤时，超80.9%将 "不红屁屁" 列为首要考量因素。《中国母婴用品消费趋势报告》也指出，2023 年敏感肌护理用品市场 规模同比激增32%，敏感肌婴幼儿群体已超两千万，但专业纸尿裤品类渗透率却不足5%。与此同时， 纸尿裤市场长期深陷两大困局：一是缺乏医学验证的统一行业标准，二是产品同质化严重，难以满足消 费者日益多元的差异化需求。 中国婴幼儿专业敏感肌 英氏控股集团董事长马文斌深情表示："舒比奇始终怀揣着一个坚定梦想，那就是打造出中国最优质的 纸尿裤产品，让每一位中国宝宝都能用上高品质、超安全的纸尿裤。"舒比奇负责人谢佳也犀利指 出："传统纸尿裤大多聚焦吸收、柔软、厚薄等基础 ...

Core Viewpoint - The article highlights the rapid growth and innovative approach of the brand "newpage," which has achieved over 100% revenue growth for three consecutive years in the Chinese infant care market, positioning itself as a leading player and a trendsetter in the industry [2]. Group 1: Brand Strategy and Market Positioning - "newpage" emphasizes a philosophy of "medical research co-creation," focusing on efficacy and high-end positioning to address the needs of parents overwhelmed by fragmented parenting information [3][5]. - The brand has launched targeted product lines for different age groups, including a repair series for children aged 6-12 and an acne control series for teenagers aged 12-18, marking a strategic upgrade to cover all age ranges [4][17]. - The marketing campaign aims to alleviate parenting anxiety by simplifying skincare choices through scientific solutions, allowing parents to trust the brand's expertise without feeling overwhelmed by options [6][12]. Group 2: Consumer Engagement and Marketing Tactics - The brand's marketing strategy leverages emotional resonance, addressing common parenting concerns through relatable scenarios, thus fostering a connection with consumers [7][10]. - Collaborations with platforms like Douyin and Tmall have enhanced brand visibility and engagement, utilizing innovative marketing tactics to reach a broader audience [10][21]. - The brand's narrative shifts from traditional marketing to a more empathetic and scientific approach, aiming to build trust and reduce decision fatigue for parents [27][28]. Group 3: Financial Performance and Market Trends - "newpage" reported a remarkable revenue growth of 498% in 2023, with a continued strong growth forecast of 161.64% for 2024, indicating robust market demand [21][22]. - The overall infant care market has seen a structural shift, with online sales in major channels increasing by 21.8%, reflecting a growing preference for domestic brands and a move towards more specialized care products [26][23]. - The brand's success is attributed to its ability to meet the evolving demands of modern parents, who prioritize product efficacy and safety, thus transforming the market from a "stock market" to a "value market" [26][27].

来源：文汇报 ■本报记者 唐闻佳 郑捷回忆，2003年，上海家化与瑞金医院皮肤科开启中国医学护肤领域最早的"医研共创"实践。这个跨 界牵手，因患者"痛点"而起。 皮肤健康不仅关乎美丽，更关乎全身健康。"研究发现，坚持皮肤屏障护理，对认知功能衰退、糖尿病 等都有一定保护作用。"近日在上海举行的全国皮肤屏障专业峰会上，瑞金医院皮肤科终身教授郑捷分 享这一前沿进展。 由瑞金医院主导的一项项研究，不仅写成论文，刷新人们对"皮肤健康"的认知，更变成了市场上的畅销 产品：被誉为"中国第一个医学护肤品"的玉泽皮肤屏障修护身体乳，多次位列平台"回购率"第一位置。 当前，我国护肤品市场正迎来前所未有的变革。《中国护肤品消费趋势报告》显示，与过去一味追求国 际大牌不同，2024年，超八成消费者表示经常购买国产护肤品。 在玉泽"叫好又叫座"的背后，"医研共创"的合作模式受到关注：瑞金医院和上海家化这两家"百年老 店"22年牵手，蹚出一条新路。 "科研基因"成国货护肤品硬核营销标签 "皮肤不仅是人体屏障，更是神经、内分泌、免疫系统'三位一体'的呈现。"郑捷介绍，近10年，三项摘 获诺贝尔奖的科研成果——Toll样受体、昼夜节律、辣椒 ...

Core Insights - The skincare market for international brands like Estée Lauder and L'Oréal is facing challenges, prompting a shift towards the medical aesthetics sector [1][4] - Estée Lauder has partnered with Jiahui Medical to establish a clinical research center focused on post-surgical skincare solutions [1][5] - The beauty industry is witnessing a trend towards "medical beauty," with brands integrating effective skincare products with medical aesthetics [4][6] Group 1: Company Strategies - Estée Lauder's brands, including La Mer and Clinique, are launching medical device products aimed at post-surgical recovery, indicating a strategic pivot towards medical aesthetics [1][5] - L'Oréal has been proactive in the medical aesthetics space, introducing products like the "Platinum Research" collagen injection and investing in high-end medical chains [6][7] - Amorepacific has also entered the market with its high-end brand "AP," focusing on post-surgical skincare products priced between 2000-3000 RMB [5][6] Group 2: Market Dynamics - The high-end skincare market is experiencing a significant decline, with Estée Lauder reporting an 8% drop in skincare sales in Q3 2024 and a further 12% in Q4 2024, leading to a total revenue loss of $300 million [4] - Competitors like Beiersdorf are also struggling, with its luxury brand La Prairie seeing a 15% sales decline in 2023 and a 6% drop in 2024 [4] - The domestic medical aesthetics market is becoming increasingly competitive, with companies like Aimeike facing growth slowdowns despite a 5.45% revenue increase in 2024 [9][10] Group 3: Future Outlook - Aimeike's acquisition of an 85% stake in Korean company REGEN for approximately 1.4 billion RMB highlights the need for companies to strengthen their technological capabilities in the face of rising competition [11] - The competition between international beauty brands and domestic medical aesthetics firms is intensifying, focusing on brand strength and clinical validation versus technological barriers and channel control [11]